TOMASETTI, CARMINE
 Distribuzione geografica
Continente #
AS - Asia 1.609
NA - Nord America 1.355
EU - Europa 1.178
SA - Sud America 319
AF - Africa 62
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.529
Nazione #
US - Stati Uniti d'America 1.288
SG - Singapore 883
RU - Federazione Russa 649
CN - Cina 356
BR - Brasile 272
IT - Italia 183
VN - Vietnam 150
HK - Hong Kong 129
DE - Germania 87
FI - Finlandia 52
IE - Irlanda 46
CA - Canada 40
GB - Regno Unito 33
CI - Costa d'Avorio 30
NL - Olanda 29
AR - Argentina 21
FR - Francia 21
SE - Svezia 21
BD - Bangladesh 19
MX - Messico 16
IN - India 13
ZA - Sudafrica 13
ID - Indonesia 11
UA - Ucraina 11
ES - Italia 9
PL - Polonia 9
AT - Austria 8
CL - Cile 6
EC - Ecuador 6
JP - Giappone 6
KR - Corea 5
PK - Pakistan 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CO - Colombia 4
KE - Kenya 4
TR - Turchia 4
AL - Albania 3
IQ - Iraq 3
OM - Oman 3
TW - Taiwan 3
UZ - Uzbekistan 3
VE - Venezuela 3
AU - Australia 2
BW - Botswana 2
BY - Bielorussia 2
CD - Congo 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
KG - Kirghizistan 2
LT - Lituania 2
MA - Marocco 2
NI - Nicaragua 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BE - Belgio 1
BS - Bahamas 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NE - Niger 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
YE - Yemen 1
Totale 4.529
Città #
Singapore 401
Chandler 165
Beijing 153
Moscow 153
Hong Kong 129
Santa Clara 119
Ashburn 97
Millbury 60
Dong Ket 42
Princeton 41
Los Angeles 39
Ho Chi Minh City 36
Nanjing 36
Des Moines 31
Napoli 28
Hefei 27
Munich 26
São Paulo 25
Redondo Beach 24
Norwalk 22
Buffalo 21
Hanoi 21
Seattle 20
Amsterdam 19
New York 19
Ottawa 19
Wilmington 18
Boston 14
Nuremberg 14
Falkenstein 12
Helsinki 12
Lawrence 11
Turku 11
Mexico City 10
Naples 10
Shenyang 10
Dhaka 9
Nanchang 9
Rio de Janeiro 9
The Dalles 9
Charlotte 8
Haiphong 8
Jacksonville 8
Montreal 8
Brooklyn 7
Changsha 7
Chicago 7
Frankfurt am Main 7
Jiaxing 7
Johannesburg 7
Porto Alegre 7
Redwood City 7
Rome 7
Atlanta 6
Dallas 6
Milan 6
Ortona 6
Toronto 6
Warsaw 6
Woodbridge 6
Belo Horizonte 5
Brasília 5
Caxias do Sul 5
Curitiba 5
Denver 5
Hebei 5
Houston 5
Montevideo 5
Phoenix 5
San Francisco 5
Seoul 5
Tokyo 5
Calgary 4
Gallipoli 4
Nairobi 4
Ninh Bình 4
Orem 4
Poplar 4
Salvador 4
Tamworth 4
Tianjin 4
Torino 4
Biên Hòa 3
Boardman 3
Caivano 3
Catania 3
Chennai 3
Da Nang 3
Dublin 3
Formosa 3
Fremont 3
Guarulhos 3
Hangzhou 3
Hortolândia 3
Macapá 3
Manaus 3
Münster 3
Portici 3
Rawalpindi 3
Salerno 3
Totale 2.222
Nome #
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 125
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 122
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 114
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 113
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 106
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 104
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 101
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 101
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 101
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 100
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 100
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 99
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 98
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 98
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 98
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 97
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 97
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 97
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 96
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 95
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 94
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 93
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions 93
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the “real world” everyday clinical practice 93
Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament 92
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 91
When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia 89
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis 86
Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors 86
The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular “Lego” in the pathophysiology of psychiatric disorders. A systematic review and translational insight 86
Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases 83
A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration 83
Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment 81
Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: A systematic review 81
Alexithymia, suicide ideation, affective temperaments and homocysteine levels in drug naïve patients with post-traumatic stress disorder: an exploratory study in the everyday ‘real world’ clinical practice 80
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 76
An update of safety of clinically used atypical antipsychotics 74
An Update on Glutamatergic System in Suicidal Depression and on the role of Esketamine 67
Novel pathways in the treatment of major depression: Focus on the glutamatergic system 66
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study 65
The role of melatonin in mood disorders 64
Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment 62
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 62
“Resistenza alla gestione farmacologica della depressione bipolare resistente: Refrattarietà vs. tolleranza a litio in pazienti precedentemente responsivi. Inquadramento clinico, cenni neurobiologici, e prospettive terapeutiche.” – Evento: “Unveiling the dark side of the mood: nuove prospettive diagnostiche e terapeutiche per il trattamento dei disturbi depressivi”. Giulianova (Teramo), 6 Ottobre 2016. 59
The Problem of Eating Disorders and Comorbid Psychostimulants Abuse - A Mini Review 57
The ‘dead man walking’ disorder: an update on Cotard’s syndrome 56
The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review 55
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials 55
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder 53
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine 53
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review 49
Suicide during perinatal period: Epidemiology, risk factors, and clinical correlates 49
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy 48
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice 47
Earthquakes, economic crisis and, now, COVID-19: the cry of yell of Central Italy 47
S-Adenosyl-L-Methionine for Major Depressive Disorder” in the book entitled:” Melatonin, Neuroprotective Agents and Antidepressant Therapy 46
Understanding the Complex of Suicide in Depression: from Research to Clinics 42
Second Generation Long-Acting Antipsychotics in the Treatment of Bipolar Disorder: A Clinical Viewpoint 28
Totale 4.653
Categoria #
all - tutte 15.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.941


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 18 6 3 10 1 7 44
2021/2022305 12 1 1 3 0 22 1 9 51 39 53 113
2022/2023370 54 21 24 9 59 49 3 36 61 23 17 14
2023/2024242 16 49 15 14 11 17 15 42 0 3 39 21
2024/20251.490 63 132 2 5 59 78 179 113 57 134 507 161
2025/20261.654 330 206 335 210 491 82 0 0 0 0 0 0
Totale 4.653